







Researchers found that individuals with PTSD exhibit lower oxytocin and higher vasopressin levels compared to non-traumatized groups. This hormonal imbalance, particularly the vasopressin-to-oxytocin ratio, could serve as a key indicator of PTSD.
"Stress Hormone" Cortisol Linked to Early Toll on Thinking Ability
Brain changes, visible on scans, are also associated with Alzheimer’s precursors

The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders
Increasing evidence suggests estrogen and estrogen signaling pathway disturbances across psychiatric disorders. Estrogens are not only crucial in sexual maturation and reproduction but are also highly involved in a wide range of brain functions, such as cognition, memory, neurodevelopment, and neuroplasticity. To add more, the recent findings of its neuroprotective and anti-inflammatory effects have grown interested in investigating its potential therapeutic use to psychiatric disorders. In this review, we analyze the emerging literature on estrogen receptors and psychiatric disorders in cellular, preclinical, and clinical studies. Specifically, we discuss the contribution of estrogen receptor and estrogen signaling to cognition and neuroprotection via mediating multiple neural systems, such as dopaminergic, serotonergic, and glutamatergic systems. Then, we assess their disruptions and their potential implications for pathophysiologies in psychiatric disorders. Further, in this review, current treatment strategies involving estrogen and estrogen signaling are evaluated to suggest a future direction in identifying novel treatment strategies in psychiatric disorders.

The Dissociation Spectrum + What Causes Dissociative Disorders?
A Balm for Psyches Scarred by War (Published 2022)
MDMA-assisted treatment for post-traumatic stress disorder “represents real hope for long-term healing,” health experts say.

Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
Accumulating data from various clinical trial studies suggests that adjuvant therapy with ovarian hormones (estrogens) could be effective in reducing cognitive deficit and psychopathological symptoms in women with psychiatric disorders. However, estrogen therapy poses serious limitations and health issues including feminization in men and increased risks of thromboembolism, hot flashes, breast hyperplasia, and endometrium hyperplasia when used for longer duration in older women (aged ≥ 60 years) or in women who have genetic predispositions. On the other hand, selective estrogen receptor modulators (SERMs), which may (or may not) carry some risks of hot flashes, thromboembolism, breast hyperplasia, and endometrial hyperplasia, are generally devoid of feminization effect. In clinical trial studies, adjuvant therapy with tamoxifen, a triphenylethylene class of SERM, has been found to reduce the frequency of manic episodes in patients with bipolar disorder, whereas addition of raloxifene, a benzothiophene class of SERM, to regular doses of antipsychotic drugs has been found to reduce cognitive deficit and psychological symptoms in men and women with schizophrenia, including women with treatment refractory psychosis. These outcomes together with potent neurocognitive, neuroprotective, and cardiometabolic properties suggest that SERMs could be the potential targets for designing effective and safer therapies for psychiatric disorders.

Social interactions may be affected by epigenetics
The DNA that encodes the oxytocin receptor undergoes chemical modifications.

Serotonin Transporters Increase When Depression Fades - Neuroscience News
Neuroimaging revealed serotonin transporter levels increased in people who were in recovery from depression following cognitive behavioral therapy.

Little evidence that chemical imbalance causes depression, UCL scientists find
Researchers question use of antidepressants, prescribed to one in six UK adults

Stress Increases Empathy in Women, Decreases It in Men
New research from Vienna finds a big gender gap in how we respond to stressful situations.

What stress does to the brain - Neuroscience News
A new study sheds light on how the brain changes as a result of chronic stress. Selective noradrenaline release rewires connectivity patterns between different brain regions. Activity in the amygdala and networks that process sensory stimuli increased.

Active Monitoring of Oxytocin Research Evidence
Active Monitoring of Oxytocin Research Evidence (AMORE) is a platform for living meta-analyses in oxytocin research.

Newly discovered brain cells explain a prosocial effect of oxytocin
Oxytocin, the body’s natural love potion, helps couples fall in love, makes mothers bond with their babies, and encourages teams to work together. Now new research reveals a mechanism by which this prosocial hormone has its effect on interactions between the sexes, at least in certain situations. The key, it turns out, is a newly discovered class of brain cells.
Brain's "Brakes" Suppress Unwanted Thoughts
Researchers identify a new target for disorders such as PTSD and schizophrenia

Why the Fear Around Hormone Therapy Won’t Die
Effective care in menopause starts with three fundamentals:

Us Versus Them: Harming the ‘Outgroup’ Is Linked to Elevated Activity in the Brain’s Reward Circuitry - Neuroscience News
Aggression toward members in an "outgroup" was associated with increased activity in areas of the brain associated with reward. Activity in the ventromedial prefrontal cortex impacted the level of aggression a person demonstrated against an outsider.

When Women Initiate Estrogen Therapy Matters | The Menopause Society
New large-scale analysis shows potential long-term benefits of initiating hormones during perimenopause
